NIH-funded research R01 grant

Investigating how RNA modifications affect Alzheimer's disease progression

Official title: Role of R-loops in transcriptional stress, genome instability, and chronic immune response in Alzheimer's disease

Funded at Purdue University · NIH-10933512 · Data updated 2026-11-12

This study is looking at how certain changes in RNA might play a part in the development of Alzheimer's disease, using fruit flies to see how these changes can cause problems in our cells and possibly lead to new treatments for the disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionPurdue University
NIH-funded
Lab location1 site (West Lafayette, United States)
Project startSeptember 22, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$472,642
NIH project number5R01NS135611-02
Project IDNIH-10933512 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults who are experiencing symptoms of Alzheimer's disease or related dementias.

Less likely to help

Patients with early-onset Alzheimer's disease or those with non-age-related forms of dementia may not benefit from this research.

What this research studies

This research focuses on understanding the role of specific RNA modifications in the development of Alzheimer's disease (AD), particularly how these modifications can lead to genome instability and chronic immune responses. By using a Drosophila model of AD, the researchers will explore how disruptions in RNA structures, known as R-loops, contribute to the disease's progression. The study aims to identify the mechanisms by which these RNA alterations affect cellular processes and may lead to new therapeutic strategies for AD.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments that address the underlying causes of Alzheimer's disease rather than just alleviating symptoms.

How similar studies have gone: Previous research has shown promising results in targeting RNA modifications for therapeutic purposes in neurodegenerative diseases, suggesting potential for success in this approach.

Where this research is happening

  • Purdue University
    West Lafayette, United States
    Active

Researchers

  • Principal investigator: Hall, Hana — Purdue University
  • Study coordinator: Hall, Hana

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.